CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSE: CRL · Wilmington, MA · Healthcare
$189.85+3.41 (+1.83%)Closed
Market Cap$9.14B
Cash$203.7Mmost recent
Runwayprofitable
P/E (TTM)—EPS $-2.91
52-Wk Range$145.05 – $226.77
Avg Volume921.6K3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$189.85-11.5%
Pipeline

Drug candidates sponsored by CHARLES RIVER LABORATORIES INTERNATIONAL · ClinicalTrials.gov

0 drugs · 0 trials
No trials found for this sponsor.
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for CRL. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.